Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Issued: 2011-2025

Historic Shares Issued for Catalyst Pharmaceuticals (CPRX) over the last 9 years, with Sep 2025 value amounting to $5.8 million.

  • Catalyst Pharmaceuticals' Shares Issued was N/A to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.8 million, marking a year-over-year change of. This contributed to the annual value of $141.0 million for FY2024, which is 4950.14% up from last year.
  • Latest data reveals that Catalyst Pharmaceuticals reported Shares Issued of $5.8 million as of Q3 2025, which was up 162.26% from $2.2 million recorded in Q2 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Shares Issued peaked at $141.0 million during Q1 2024, and registered a low of $188,000 during Q1 2021.
  • In the last 3 years, Catalyst Pharmaceuticals' Shares Issued had a median value of $1.7 million in 2023 and averaged $19.6 million.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Shares Issued skyrocketed by 11,002.36% in 2024 and then plummeted by 96.60% in 2025.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Shares Issued stood at $685,000 in 2021, then skyrocketed by 367.30% to $3.2 million in 2022, then slumped by 78.35% to $693,000 in 2023, then surged by 11,002.36% to $141.0 million in 2024, then plummeted by 96.60% to $5.8 million in 2025.
  • Its Shares Issued was $5.8 million in Q3 2025, compared to $2.2 million in Q2 2025 and $4.8 million in Q1 2025.